By Susan Smith

Published in: Sci of Stability Conference

Published on: August 14, 2019

Conclusions: • Product knowledge underpins understanding of the stability-related risks associated with the product • Scientific rationale combined with product understanding has been used to leverage lean stability strategies throughout development • However, a unified regulatory position to science- and risk-based stability strategies does not exist at present, potentially leading to conservatism within drug companies • Although challenges remain both within companies and externally from regulators these case studies demonstrate that many scientifically sound lean strategies are acceptable from a regulatory perspective Key Words: Biologic, Bracket, Annual

Advance Stability Knowledge

Would you like to see a particular publication, guidance, organization, supplier, event, or career opportunity on StabilityHub? Contact us with your suggestion!